Showing results (31-40 of 170) with videos related to
Sort By:
Pageof 17
Biomarker Research|February 12, 2014
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignanciesUgo Testa, Elvira Pelosi, Arthur FrankelCurrent Oncology (Toronto, Ont.)|January 20, 2023
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted TherapiesUgo Testa, Germana Castelli, Elvira PelosiExpert Review of Molecular Diagnostics|December 2, 2022
Clinical value of identifying genes that inhibit hepatocellular carcinomasUgo Testa, Elvira Pelosi, Germana CastelliCancers|September 21, 2017
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem CellsGermana Castelli, Elvira Pelosi, Ugo TestaMedicines (Basel, Switzerland)|August 6, 2020
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic TargetsUgo Testa, Elvira Pelosi, Germana CastelliBiomedicines|October 17, 2020
Genetic Alterations of Metastatic Colorectal CancerUgo Testa, Germana Castelli, Elvira PelosiAnnali Dell'Istituto Superiore Di Sanita|September 22, 2020
Cancer stem cell targeted therapiesUgo Testa, Elvira Pelosi, Germana CastelliMedical Sciences (Basel, Switzerland)|April 14, 2018
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cellsUgo Testa, Elvira Pelosi, Germana CastelliInternational Journal of Molecular Sciences|February 11, 2023
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic NeoplasmElvira Pelosi, Germana Castelli, Ugo TestaJournal of Clinical Medicine|February 27, 2026
Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell TransplantationUgo Testa, Germana Castelli, Elvira PelosiPageof 17